Proactive Investors - Run By Investors For Investors

Curnamona Energy go-ahead for Oban uranium project field trial


Curnamona Energy (ASX:CUY) has announced that the Mining and Rehabilitation Program (MARP) for the proposed Oban field trial in South Australia has now been approved by PIRSA.

The MARP is a comprehensive document that outlines the proposed field trial activities for uranium recovery on Retention Lease (RL) 123, the likely effects on the environment, required risk mitigation measures and final closure procedures.

Subject to payment of a rehabilitation bond to PIRSA and procurement of several Environmental Protection Authority (EPA) approvals, including a Radiation Management Plan and a Radioactive Waste Management Plan, the field trial may proceed.

In the meantime, negotiations are continuing for the design and construction of the field trial treatment plant with experienced consulting engineering groups. Following receipt of outstanding EPA approvals, Curnamona Energy will move as quickly as possible to construct the trial treatment plant and carry out the planned test work, for which it has the funds in hand.

Subject to a successful outcome of the test, Curnamona Energy will then apply for a Mining Lease and proceed to obtain an Export Licence and other approvals required for commercial uranium mining. A proposal for a mining lease will require assessment under the Environment Protection and Biodiversity Conservation Act and the South Australian Mining Act to cover the situation of a full scale in situ recovery (ISR) mining operation.

Curnamona Energy is 45% owned by Havilah Resources (ASX:HAV).

View full CUY profile View Profile

Curnamona Energy Limited Timeline

Related Articles

page of words with the word acquisition highlighted in yellow
October 05 2018
A comprehensive exploration program will commence upon transaction completion.

© Proactive Investors 2019

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use